Biomarkers of Pain and Stress Perception and Dry Needling Technique Application
Changes in Biomarkers of Pain and Stress Perception After the Application of a Dry Needling Technique in Patients With Low Back Pain
1 other identifier
interventional
36
1 country
1
Brief Summary
The use of the dry needling technique has become widespread in recent years for the treatment of musculoskeletal pain. Although dry needling has been shown to be effective in the treatment of shoulder pain, elbow pain, headache, etc., we do not yet have a clear understanding of the mechanisms of action that justify its beneficial effects. In this study, we propose to analyse the biochemical markers of pain generated by the application of a dry needling technique on the lumbar musculature in patients with mechanical lumbar pain of non-specific origin. The aim of this study will be to evaluate the effects of dry needling technique on the plasmatic concentration of biochemical markers.Furthermore, the test subjects will be randomly distributed into two groups. An experimental group where the subjects will receive a real dry needling technique. Another group will be treated with a sham technique.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable low-back-pain
Started Apr 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 4, 2024
CompletedFirst Posted
Study publicly available on registry
April 9, 2024
CompletedStudy Start
First participant enrolled
April 12, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 15, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 15, 2024
CompletedDecember 19, 2024
December 1, 2024
8 months
April 4, 2024
December 18, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Extracting Blood Samples and Obtaining Serum/Plasma
Serum samples will be extracted by venipuncture at the cubital fossa, according to a standardized protocol. Blood will be collected in a tube for serum (Vacutainer SST II Advance, model 367953) and a tube for plasma (Vacutainer PST II Advance, model 367374) separation. Substances related to antinociception will be determined later: Dopamine, adrenaline, norepinephrine, cortisol.
Change from Baseline concentration at 2 hours
Study Arms (2)
Real dry needling
EXPERIMENTALSubjects included in this group will receive a session with dry needling in the quadratus lumborum muscle.
Sham dry needling
SHAM COMPARATORSubjects included in this group will receive a session with sham dry needling in the quadratus lumborum muscle.
Interventions
Subjects will be treated with dry needling to the quadratus lumborum muscle. To do this, the subject will be lying laterally on the contralateral side and with the hip in an adducted position. Ten incisions will be made in the muscle. The head will rest comfortably on a pillow
Subjects will be treated with dry needling to the quadratus lumborum muscle. To do this, the subject will be lying laterally on the contralateral side and with the hip in an adducted position. The placebo needle will move 10 times imitating the real procedure. The head will rest comfortably on a pillow
Eligibility Criteria
You may qualify if:
- Mechanical lumbar pain of more than three months of evolution.
You may not qualify if:
- Medical diagnosis of lumbar disc herniation or protrusion.
- Low back and leg pain.
- Pregnancy.
- Fibromyalgia.
- Fear of needles.
- Medication with anticoagulants
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Centro Investigación Fisioterapia y Dolor
Alcalá de Henares, Madrid, 28805, Spain
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Tomas Gallego-Izquierdo, PhD
Centro de Investigación Fisioterapia y Dolor
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal investigator
Study Record Dates
First Submitted
April 4, 2024
First Posted
April 9, 2024
Study Start
April 12, 2024
Primary Completion
December 15, 2024
Study Completion
December 15, 2024
Last Updated
December 19, 2024
Record last verified: 2024-12